16th Annual Report 2011-12 - Fortis Healthcare

50 16th Annual Report 2011-12 Operations Review
` 15.5 Crore. During the year, the
Company commenced operations
of its Histopathology Department
to further strengthen its In-house
Test Menu and significantly reduce
send outs to India to strengthen its
image as a Reference Laboratory.
It entered into new markets, viz.,
KSA, Qatar, Kuwait, and Sudan
wherein the agents were finalised
and the logistics system was put
into place. It further expanded its
Sales network across the UAE,
Oman, Bahrain, Saudi Arabia and
Kuwait. SRL Dubai became the
first non–European lab to provide
diagnostic services to the Bahrain
Defence Force (BDF) Hospital, an
autonomous healthcare body for
Bahrain’s security services.
of cutting-edge technology and
the hospital’s focus on education
and research. This two pronged
approach of expertise and
innovation ties in well with FCH’s
service strategy to improve the
quality of colorectal treatment in
the region. FCH witnessed its soft
launch in mid-June (2012) with
clinical services (ambulatory/
day surgery). Full clinical
services, including in-patients and
major surgeries, commenced in
July 2012.
The hospital held the first
workshop on Video Assisted Anal
Fistula Treatment (VaaFT) in
Singapore, hosting its Italian
inventor and other pioneers of
this novel, minimally invasive
technique for treating complex
fistulae. Consistent with the
business strategy of being at the
leading edge of colorectal surgery,
FCH entered into a partnership with
the Institute of Bioengineering
and Nanotechnology to jointly
conduct research into colorectal
cancer genetics.
Separately, our affiliate Fortis
Novena Colorectal Centre, in
Singapore, offers comprehensive
and integrated colorectal care,
including genetic testing, treatment
of pelvic floor disorders and video
assisted anal fistula treatment.
This dedicated group practice with
specialised out-patient services
also acts as a referral centre for the
Fortis Colorectal Hospital where
advanced cases can be treated.
SRL Dubai
The Company is a premier
pathology lab servicing the
outsourcing market in the
UAE and the GCC countries.
The business comprises of one
reference lab in the UAE and seven
collection agents in the GCC. For
the period under consolidation, the
Company reported revenues of
` 4.1 Crore, while for the full
year proforma revenues stood at
Fortis Clinique Darné,
Mauritius
The 110 bed hospital in
Mauritius is amongst the most
reputed hospitals in the country
and specialises in the areas of
Cardiac Sciences, Neuro Sciences,
Orthopaedics, Pulmonology and
Obstetrics & Gynaecology, among
others. During the year, the
hospital hosted the second edition
of the Cardiac Sciences Congress
which included a courtesy visit to
the President of the Republic of
Mauritius, by renowned doctors
from Fortis. This strengthened
its reputation as a leader in the
Cardiac Sciences and Critical Care
segment. The hospital commenced
its Centre of Excellence (CoE)
in Renal Sciences with the
appointment of a senior urologist.
It strengthened its offering in
Minimal Access Surgery/bloodless
surgery through the introduction
of the Harmonic Scalpel. The
hospital launched a Preventive
Health Check programme as an
independent SBU, along with